youtube_live
Q3 2026 earnings • 4:05 PM today
See detailschevron_right
RCUS:NYSE
Arcus Biosciences Inc
$19.26
arrow_upward
+1.80%(+0.34) 1D
Nov 4, 3:27:16 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RCUS...
Open
$19.51
High
$19.63
Low
$18.60
Mkt. cap
2.76B
Avg. vol.
2.24M
Volume
795.67K
52-wk high
$31.74
52-wk low
$17.43
EPS
-$3.90
Beta
1.04
Shares outstanding
141.62M
No. of employees
601
Open
$19.51
High
$19.63
Low
$18.60
Mkt. cap
2.76B
Avg. vol.
2.24M
Volume
795.67K
52-wk high
$31.74
52-wk low
$17.43
EPS
-$3.90
Beta
1.04
Shares outstanding
141.62M
No. of employees
601
News stories
From web sources and news partners
Investing.com
·
4 hours ago
All eyes on Arcus Biosciences earnings amid cancer drug progress
Benzinga
·
2 days ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
About Arcus Biosciences Inc
Analyst ratings
Based on 13 analysts giving stock ratings to RCUS in the past 3 months
Buy
Buy
9
Hold
4
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for RCUS in the last 3 months.
Highest
Current $19.26
$50.00 (+159.61%)
Average
$40.25 (+108.98%)
Lowest
$23.00 (+19.42%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Yigal Nochomovitz Citi | Buy | Maintained | $50.00 | +159.6% | 10/25/2026 |
Terence Flynn Morgan Stanley | Hold | Maintained | $23.00 | +19.4% | 10/20/2026 |
Supawat Thongthip Truist Financial | Hold | Maintained | $41.00 | +112.9% | 10/21/2026 |
Jason Zemansky Bank of America Securities | Hold | Maintained | $29.00 | +50.6% | 10/20/2026 |
Salim Syed Mizuho Securities | Buy | Maintained | $47.00 | +144% | 10/20/2026 |
Richard Law CFA Goldman Sachs | Buy | Maintained | $42.00 | +118.1% | 10/19/2026 |
Unknown Analyst William Blair | Buy | Initiated | $50.00 | +159.6% | 10/15/2026 |
Priyanka Grover J.P. Morgan | Buy | Initiated | $41.00 | +112.9% | 10/14/2026 |
Charles Zhu LifeSci Capital | Buy | Maintained | $46.00 | +138.8% | 10/03/2026 |
Robert Driscoll Wedbush | Buy | Maintained | $43.00 | +123.3% | 09/30/2026 |
Emily Bodnar H.C. Wainwright | Buy | Maintained | $45.00 | +133.6% | 09/25/2026 |
Tara Bancroft TD Cowen | Buy | Initiated | - | - | 09/16/2026 |
Eva Fortea Verdejo Wells Fargo | Hold | Reiterated | $26.00 | +35% | 08/06/2026 |
Unknown Analyst Mizuho Securities | Buy | Maintained | $47.00 | +144% | 06/10/2026 |
Gregory Renza Truist Financial | Buy | Initiated | $35.00 | +81.7% | 05/18/2026 |
Daina Graybosch Leerink Partners | Buy | Maintained | $47.00 | +144% | 04/20/2026 |
Jonathan Miller Evercore ISI | Buy | Maintained | - | - | 03/02/2026 |
Asthika Goonewardene Truist Financial | Buy | Reiterated | $30.00 | +55.8% | 02/27/2026 |
Next call in 37:02
Today, 4:05 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / -$0.89
Revenue / Est. (USD)
- / 8.27M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 26.00M | 33.00M | 17.00M | 41.00M |
Cost of goods sold | 141.00M | 121.00M | 122.00M | 113.00M |
Cost of revenue | 141.00M | 121.00M | 122.00M | 113.00M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 27.00M | 26.00M | 29.00M | 24.00M |
Operating expense | 27.00M | 26.00M | 29.00M | 24.00M |
Total operating expenses | 168.00M | 147.00M | 151.00M | 137.00M |
Operating income | -142.00M | -114.00M | -134.00M | -96.00M |
Other non operating income | - | - | - | - |
EBT including unusual items | -135.00M | -106.00M | -128.00M | -91.00M |
EBT excluding unusual items | -135.00M | -106.00M | -128.00M | -91.00M |
Income tax expense | - | - | - | - |
Effective tax rate | - | - | - | - |
Other operating expenses | - | - | - | - |
Net income | -135.00M | -106.00M | -128.00M | -91.00M |
Net profit margin | -519.23% | -321.21% | -752.94% | -221.95% |
Earnings per share | -1.27 | -0.89 | -1.02 | -0.72 |
Interest and investment income | 10.00M | 10.00M | 9.00M | 8.00M |
Interest expense | -3.00M | -2.00M | -3.00M | -3.00M |
Net interest expenses | 7.00M | 8.00M | 6.00M | 5.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -140.00M | -111.00M | -132.00M | -93.00M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events